Paul Durrington

Paul Durrington

UNVERIFIED PROFILE

Are you Paul Durrington?   Register this Author

Register author
Paul Durrington

Paul Durrington

Publications by authors named "Paul Durrington"

Are you Paul Durrington?   Register this Author

100Publications

2115Reads

32Profile Views

Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia.

Curr Opin Lipidol 2019 Aug;30(4):263-272

Department of Medicine, Central Manchester University Hospitals NHS Foundation Trust.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000614DOI Listing
August 2019

The Reaven syndrome: An historical perspective.

Diab Vasc Dis Res 2019 03;16(2):116-117

1 Core Technology Facility, Cardiovascular Research Group, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164119828899DOI Listing
March 2019

Reply to: "Comments on 'Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk' ".

Atherosclerosis 2019 Feb 28;281:214-215. Epub 2018 Nov 28.

Cardiovascular Research Group, Faculty of Biology, Medicine and Health, University of Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2018.11.033DOI Listing
February 2019

Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk.

Atherosclerosis 2018 11 30;278:135-142. Epub 2018 Aug 30.

Cardiovascular Research Group, Faculty of Biology, Medicine and Health, University of Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2018.08.040DOI Listing
November 2018

Acquired low cholesterol: diagnosis and relevance to safety of low LDL therapeutic targets.

Curr Opin Lipidol 2018 08;29(4):318-326

Lipoprotein Research Group, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000526DOI Listing
August 2018

Evidence for more intensive cholesterol lowering.

Curr Opin Lipidol 2017 Aug;28(4):291-299

aDepartment of Medicine, Central Manchester University Hospitals NHS Foundation Trust. bLipoprotein Research Group, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Core Technology Facility, Manchester, UK.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00041433-201708000-0000
Publisher Site
http://dx.doi.org/10.1097/MOL.0000000000000433DOI Listing
August 2017

Editorial introduction.

Curr Opin Lipidol 2017 08;28(4)

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00041433-201708000-0000
Publisher Site
http://dx.doi.org/10.1097/MOL.0000000000000439DOI Listing
August 2017

Evidence-based goals in LDL-C reduction.

Clin Res Cardiol 2017 Apr 25;106(4):237-248. Epub 2017 Jan 25.

Cardiovascular Research Group, School of Biomedicine, University of Manchester, Core Technology Facility, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-016-1069-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360845PMC
April 2017

Cholesterol Levels Should Play a More Important Role in Identifying Statin Recipients.

Circulation 2017 02;135(7):627-629

From Cardiovascular Research Group, School of Biomedicine, University of Manchester, UK (P.N.D.); and Cardiovascular Trials Unit, University Department of Medicine, Central Manchester University Hospitals NHS Foundation Trust, UK (H.S.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.116.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022146DOI Listing
February 2017

Are recent statin recommendations to employ fixed doses and abandon targets effective for treatment of hypercholesterolaemia? Investigation based on number needed to treat.

Eur J Prev Cardiol 2017 01 8;24(1):76-83. Epub 2016 Sep 8.

Cardiovascular Research Group, University of Manchester, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487316667785DOI Listing
January 2017

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.

J Med Genet 2016 12 1;53(12):835-845. Epub 2016 Sep 1.

Department of Atherosclerosis Research, Children's Hospital Oakland Research Institute, Oakland, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2016-103966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309131PMC
December 2016

Diabetic dyslipidaemia.

Curr Opin Lipidol 2016 08;27(4):313-22

aCardiovascular Research Group, School of Biomedicine, University of Manchester bUniversity Department of Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000318DOI Listing
August 2016

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).

Diabetologia 2016 Feb 17;59(2):299-306. Epub 2015 Nov 17.

Diabetes Epidemiology Unit, Division of Population Health Sciences, University of Dundee, The Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-015-3802-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705133PMC
February 2016

Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment.

Eur Heart J 2015 Nov 4;36(43):2975-83. Epub 2015 Aug 4.

Cardiovascular Research Group, School of Biomedicine, University of Manchester, Core Technology Facility (3rd Floor), 46 Grafton Street, Manchester M13 9NT, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehv340DOI Listing
November 2015

Antioxidant properties of HDL.

Front Pharmacol 2015 16;6:222. Epub 2015 Oct 16.

Cardiovascular Research Group, Core Technology Facility, University of Manchester Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2015.00222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607861PMC
November 2015

Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.

J Am Heart Assoc 2015 Sep 15;4(9):e001508. Epub 2015 Sep 15.

Cardiovascular Research Group, Core Technologies Facility, University of Manchester, United Kingdom (R.Y., Y.L., S.H., M.F., J.S., T.J.S., R.M., P.D., H.S.) Cardiovascular Trials Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom (R.Y., S.K., M.F., R.E., J.S., H.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.114.001508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599486PMC
September 2015

Unintended positive and negative effects of drugs on lipoproteins.

Curr Opin Lipidol 2015 Aug;26(4):325-37

aCardiovascular Research Group, School of Medicine, Core Technology Facility (3rd Floor), University of Manchester bCardiovascular Trials Unit, Central Manchester and Manchester Children University Hospital NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000198DOI Listing
August 2015

How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.

Curr Opin Lipidol 2015 Aug;26(4):247-56

aCardiovascular Research Group, School of Medicine, Core Technology Facility, University of Manchester bCardiovascular Trials Unit, Central Manchester and Manchester Children University Hospital NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000194DOI Listing
August 2015

With statin co-administration, drugs designed to increase HDL have no impact on cardiovascular outcomes.

Evid Based Med 2015 Feb 23;20(1):12. Epub 2014 Sep 23.

Cardiovascular Research Group, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://ebm.bmj.com/lookup/doi/10.1136/ebmed-2014-110084
Publisher Site
http://dx.doi.org/10.1136/ebmed-2014-110084DOI Listing
February 2015

Response letter to the editor.

J Clin Endocrinol Metab 2015 Jan;100(1):L12

Cardiovascular Research Group Core Technologies Facility University of Manchester Manchester UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2014-4212DOI Listing
January 2015

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.

Authors:
Iris Postmus Stella Trompet Harshal A Deshmukh Michael R Barnes Xiaohui Li Helen R Warren Daniel I Chasman Kaixin Zhou Benoit J Arsenault Louise A Donnelly Kerri L Wiggins Christy L Avery Paula Griffin QiPing Feng Kent D Taylor Guo Li Daniel S Evans Albert V Smith Catherine E de Keyser Andrew D Johnson Anton J M de Craen David J Stott Brendan M Buckley Ian Ford Rudi G J Westendorp P Eline Slagboom Naveed Sattar Patricia B Munroe Peter Sever Neil Poulter Alice Stanton Denis C Shields Eoin O'Brien Sue Shaw-Hawkins Y-D Ida Chen Deborah A Nickerson Joshua D Smith Marie Pierre Dubé S Matthijs Boekholdt G Kees Hovingh John J P Kastelein Paul M McKeigue John Betteridge Andrew Neil Paul N Durrington Alex Doney Fiona Carr Andrew Morris Mark I McCarthy Leif Groop Emma Ahlqvist Joshua C Bis Kenneth Rice Nicholas L Smith Thomas Lumley Eric A Whitsel Til Stürmer Eric Boerwinkle Julius S Ngwa Christopher J O'Donnell Ramachandran S Vasan Wei-Qi Wei Russell A Wilke Ching-Ti Liu Fangui Sun Xiuqing Guo Susan R Heckbert Wendy Post Nona Sotoodehnia Alice M Arnold Jeanette M Stafford Jingzhong Ding David M Herrington Stephen B Kritchevsky Gudny Eiriksdottir Leonore J Launer Tamara B Harris Audrey Y Chu Franco Giulianini Jean G MacFadyen Bryan J Barratt Fredrik Nyberg Bruno H Stricker André G Uitterlinden Albert Hofman Fernando Rivadeneira Valur Emilsson Oscar H Franco Paul M Ridker Vilmundur Gudnason Yongmei Liu Joshua C Denny Christie M Ballantyne Jerome I Rotter L Adrienne Cupples Bruce M Psaty Colin N A Palmer Jean-Claude Tardif Helen M Colhoun Graham Hitman Ronald M Krauss J Wouter Jukema Mark J Caulfield

Nat Commun 2014 Oct 28;5:5068. Epub 2014 Oct 28.

1] NIHR Barts Cardiovascular Biomedical Research Unit, Queen Mary University of London, London EC1M 6BQ, UK [2] Department of Clinical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London EC1M6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220464PMC
October 2014

Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea.

J Clin Endocrinol Metab 2014 Sep 13;99(9):3390-8. Epub 2014 May 13.

Cardiovascular Research Group (R.Y., M.F., R.A., Y.L., S.H., S.K., J.S., R.M., A.G., P.D., M.J., H.S.), Core Technologies Facility, University of Manchester, Manchester M13 9PT, United Kingdom; Cardiovascular Trials Unit (R.Y., M.F. S.K., J.S., H.S.) and Department of Clinical Biochemistry (M.F., P.P.), Central Manchester University Hospitals, National Health Service Foundation Trust, Manchester M13 9WL, United Kingdom; and Departments of Medicine (P.T., A.A.S.) and Surgery (B.A.), the North West Diabetes Local Research Network (M.G.), Salford Royal National Health Service Foundation Trust, Salford M6 8HD, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-3939DOI Listing
September 2014

Lipoprotein (a): gene genie.

Curr Opin Lipidol 2014 Aug;25(4):289-96

aCardiovascular Research Group, School of Biomedicine, University of Manchester bCardiovascular Trials Unit, University Department of Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000096DOI Listing
August 2014

The importance of considering LDL cholesterol response as well as cardiovascular risk in deciding who can benefit from statin therapy.

Curr Opin Lipidol 2014 Aug;25(4):239-46

aCardiovascular Research Group, School of Biomedicine, University of Manchester, bCardiovascular Trials Unit, University Department of Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-lipidology/2014/08000/The_im
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MOL.0000000000000097DOI Listing
August 2014

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Circulation 2013 Oct 21;128(14):1504-12. Epub 2013 Aug 21.

Departments of Cardiology (S.M.B.) and Vascular Medicine (B.J.A., G.K.H., J.J.P.K.), Academic Medical Center, Amsterdam, The Netherlands; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, MA (S.M., P.M.R.); Center of Preventive Medicine, Oslo University Hospital, Ulleval and University of Oslo, Norway (T.R.P.); State University of New York Health Science Center, Brooklyn, NY (J.C.L.); Rosalind Franklin University of Medicine and Science, North Chicago, IL (K.M.A.W.); Department of Neurology and Stroke Center, Bichat University Hospital, Paris, France (P.A.); Global Pharmaceuticals Pfizer, New York, NY (D.A.D.); Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia (A.M.T.); Department of Biochemistry and Lipid Clinic, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (D.R.S.); NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia (A.K.); Medical Research Institute, University of Dundee, Dundee, United Kingdom (H.M.C.); Centre for Diabetes, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (G.A.H.); Department of Medicine, Royal Free and University College Medical School, London, United Kingdom (D.J.B.); School of Biomedicine, University of Manchester, Manchester, United Kingdom (P.N.D.); Touro University, Mare Island, CA (M.B.C.); Department of Medicine, University of Texas Health Science Center, and VERDICT, South Texas Veterans Health Care System, San Antonio, TX (J.R.D.); and Weill Cornell Medical College, New York, NY (A.M.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807966PMC
October 2013

Atorvastatin administration is associated with dose-related changes in IGF bioavailability.

Eur J Endocrinol 2013 Apr 15;168(4):543-8. Epub 2013 Mar 15.

Salford Royal Hospital NHS Foundation Trust, The University of Manchester, Salford, UK.

View Article

Download full-text PDF

Source
https://eje.bioscientifica.com/view/journals/eje/168/4/543.x
Publisher Site
http://dx.doi.org/10.1530/EJE-12-0844DOI Listing
April 2013

High-density lipoprotein impedes glycation of low-density lipoprotein.

Diab Vasc Dis Res 2013 Mar 13;10(2):152-60. Epub 2012 Aug 13.

Cardiovascular Research Group, School of Biomedicine, University of Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164112454309DOI Listing
March 2013

Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes.

Clin Sci (Lond) 2013 Mar;124(5):343-9

Cardiovascular Research Group, School of Biomedicine, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CS20120304DOI Listing
March 2013

HDL functionality.

Curr Opin Lipidol 2012 Aug;23(4):353-66

University Department of Medicine, Central Manchester and Manchester Children University Hospital NHS Foundation Trust, School of Biomedicine, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0b013e328355ca25DOI Listing
August 2012

Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.

Ann Clin Biochem 2011 Nov 17;48(Pt 6):566-71. Epub 2011 Oct 17.

Cardiovascular Research Group, School of Biomedicine, Core Technology Facility, 3rd Floor, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/acb.2011.010277DOI Listing
November 2011

Susceptibility of LDL and its subfractions to glycation.

Curr Opin Lipidol 2011 Aug;22(4):254-61

Cardiovascular Research Group, School of Biomedicine, Core Technology Facility, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0b013e328348a43fDOI Listing
August 2011

Proteinuria and severe mixed dyslipidemia associated with a novel APOAV gene mutation.

J Clin Lipidol 2010 Jul-Aug;4(4):310-3. Epub 2010 Jul 7.

Cardiovascular Research Group, School of Clinical & Laboratory Sciences, University of Manchester, Core Technology Facility (3(rd) Floor), 46 Grafton Street, Manchester M139NT, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2010.06.004DOI Listing
June 2011

Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes.

Diab Vasc Dis Res 2010 Oct 27;7(4):289-95. Epub 2010 Sep 27.

Cardiovascular Research Group, School of Clinical & Laboratory Sciences, University of Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164110383063DOI Listing
October 2010

Indices of obesity and cardiovascular risk factors in British women.

Obes Facts 2008 14;1(4):190-5. Epub 2008 Aug 14.

School of Clinical and Laboratory Sciences, University of Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000148778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452116PMC
July 2010

Increased C-reactive protein levels in overweight and obese women taking exogenous hormones: the United Kingdom Women's Heart Study (UKWHS).

Clin Endocrinol (Oxf) 2009 Nov 6;71(5):727-32. Epub 2009 Mar 6.

Cardiovascular Research Group, School of Clinical & Laboratory Sciences, University of Manchester, 46 Grafton Street, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2265.2009.03580.xDOI Listing
November 2009

Variation in paraoxonase-1 activity and atherosclerosis.

Curr Opin Lipidol 2009 Aug;20(4):265-74

University Department of Medicine, Central Manchester and Manchester Children's University Hospitals Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-lipidology/2009/08000/Variat
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MOL.0b013e32832ec141DOI Listing
August 2009

Cost effectiveness of ezetimibe in patients with cardiovascular disease and statin intolerance or contraindications: a Markov model.

Am J Cardiovasc Drugs 2008 ;8(6):419-27

Health Economics and Decision Science, ScHARR, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/0129784-200808060-00005.DOI Listing
April 2009

The first recorded heterozygote for familial hypercholesterolemia.

J Clin Lipidol 2009 Apr 11;3(2):146-8. Epub 2009 Feb 11.

Cardiovascular Research Group, School of Clinical & Laboratory Sciences, Core Technology Facility (3rd Floor), University of Manchester, 46 Grafton Street, Manchester M13 9NT, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2009.02.002DOI Listing
April 2009

Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro.

Atherosclerosis 2009 Jan 26;202(1):162-8. Epub 2008 Apr 26.

Cardiovascular Research Group, Core Technology Facility (3rd Floor), University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002191500800275
Publisher Site
http://dx.doi.org/10.1016/j.atherosclerosis.2008.04.036DOI Listing
January 2009

Use of the TLX ultracentrifuge for the isolation of different density lipoproteins and effects of freeze/thawing of human plasma before ultracentrifugation.

Clin Chem Lab Med 2008 ;46(9):1285-8

Cardiovascular Research Group, School of Clinical and Laboratory Sciences, Core Technology Facility, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2008.254DOI Listing
December 2008

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.

Eur Heart J 2008 Nov 7;29(21):2625-33. Epub 2008 Oct 7.

NIHR School of Primary Care Research, Division Public Health and Primary Health Care, University of Oxford, Old Road Headington, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehn422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577142PMC
November 2008

Familial hypobetalipoproteinemia due to a novel early stop mutation.

J Clin Lipidol 2008 Oct 23;2(5):384-90. Epub 2008 Aug 23.

Cardiovascular Research Group, Division of Cardiovascular and Endocrine Science, Core Technology Facility, 3rd Floor, University of Manchester, 46 Garfton Street, Manchester M13 9NT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2008.08.446DOI Listing
October 2008

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

Diab Vasc Dis Res 2008 Sep;5(3):177-83

Department of Medicine, New York University School of Medicine, VA Hospital, 423 East 23rd Street, Dept of Medicine -11093 South, New York, NY 10010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3132/dvdr.2008.029DOI Listing
September 2008

Glycation as an atherogenic modification of LDL.

Curr Opin Lipidol 2008 Aug;19(4):378-84

Department of Biochemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-lipidology/2008/08000/Glycat
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MOL.0b013e328306a057DOI Listing
August 2008

Rosuvastatin: efficacy, safety and clinical effectiveness.

Expert Opin Pharmacother 2008 Aug;9(12):2145-60

Central Manchester and Manchester Children University Hospital, Department of Endocrinology, Oxford Road, Manchester M13 9WL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.9.12.2145DOI Listing
August 2008

Hypercholesterolaemia and its management.

BMJ 2008 Aug 21;337:a993. Epub 2008 Aug 21.

University of Manchester Cardiovascular Research Group, Core Technology Facility, Manchester M13 9NT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.a993DOI Listing
August 2008

Patients' understandings and experiences of familial hypercholesterolemia.

Community Genet 2008 20;11(5):273-82. Epub 2008 May 20.

Institute for Science and Society, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000121398DOI Listing
July 2008

Alstrom syndrome (OMIM 203800): a case report and literature review.

Orphanet J Rare Dis 2007 Dec 21;2:49. Epub 2007 Dec 21.

Department of Vascular Biology and Medicine, Robarts Research Institute and Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1750-1172-2-49DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266715PMC
December 2007

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Eur J Cardiovasc Prev Rehabil 2007 Sep;14 Suppl 2:E1-40

Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Doublin, Ireland.

View Article

Download full-text PDF

Source
https://www.escardio.org/static_file/Escardio/Press-media/gu
Web Search
http://eurheartj.oxfordjournals.org/content/ehj/28/19/2375.f
Web Search
http://cpr.sagepub.com/lookup/doi/10.1097/01.hjr.0000277984.
Publisher Site
http://dx.doi.org/10.1097/01.hjr.0000277984.31558.c4DOI Listing
September 2007

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Eur J Cardiovasc Prev Rehabil 2007 Sep;14 Suppl 2:S1-113

Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.hjr.0000277983.23934.c9DOI Listing
September 2007

Molecular characterization of two patients with severe LCAT deficiency.

Nephrol Dial Transplant 2007 Aug 25;22(8):2379-82. Epub 2007 May 25.

Cardiovascular Research Group, University of Manchester, Manchester Royal Infirmary, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfm311DOI Listing
August 2007

The robustness of the Roche 2nd generation homogenous HDL cholesterol (PEGME) method: assessment of the effect of serum sample storage for up to 8 years at -80 degrees C.

Clin Chim Acta 2007 Jul 24;382(1-2):142-4. Epub 2007 Apr 24.

Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, Core Technology Facility (3rd Floor), University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2007.04.009DOI Listing
July 2007

Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.

J Nephrol 2006 Nov-Dec;19(6):732-8

Second Department of Medicine and Nephrological Centre, University of Pecs, Pecs, Hungary.

View Article

Download full-text PDF

Source
April 2007

Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential.

Drugs 2007 ;67(1):11-6

Division of Cardiovascular and Endocrine Sciences, Cardiovascular Research Group, Core Technology Facility, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003495-200767010-00002DOI Listing
March 2007

Does statin therapy improve short-term clinical outcomes in acute coronary syndromes?

Authors:
Paul Durrington

Nat Clin Pract Cardiovasc Med 2006 Nov;3(11):592-3

Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, Core Technology Facility, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpcardio0687DOI Listing
November 2006

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).

Diabetes Care 2006 Nov;29(11):2378-84

Division of Public Health and Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/cgi/doi/10.2337/dc06-0872
Publisher Site
http://dx.doi.org/10.2337/dc06-0872DOI Listing
November 2006

Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy.

Am J Hum Genet 2006 Aug 5;79(2):383-9. Epub 2006 Jun 5.

Robarts Research Institute, 406-100 Perth Drive, London, Ontario, Canada N6A 5K8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/505885DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559499PMC
August 2006

Adiponectin in umbilical cord blood is inversely related to low-density lipoprotein cholesterol but not ethnicity.

J Clin Endocrinol Metab 2006 Jun 21;91(6):2244-9. Epub 2006 Mar 21.

Clinical Epidemiology Group, University of Manchester Medical School, Stopford Building, Oxford Road, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2005-2714DOI Listing
June 2006

Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate.

Clin Chem 2006 Mar 19;52(3):453-7. Epub 2006 Jan 19.

Division of Cardiovascular and Endocrine Sciences, Department of Medicine, Manchester Royal Infirmary, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2005.063412DOI Listing
March 2006

Cord blood lipoproteins and prenatal influences.

Curr Opin Lipidol 2005 Aug;16(4):400-8

Clinical Epidemiology & Cardiovascular Medicine Group, Division of Cardiovascular and Endocrine Science, University Department of Medicine, Manchester Royal Infirmary, UK.

View Article

Download full-text PDF

Source
August 2005

The effect of atorvastatin on serum lipoproteins in acromegaly.

Clin Endocrinol (Oxf) 2005 Jun;62(6):650-5

Cardiovascular, Medicine and Surgery Central Clinical Academic Group, University of Manchester, M13 9PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2265.2005.02273.xDOI Listing
June 2005

Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.

Gynecol Endocrinol 2005 Mar;20(3):176-82

Department of Diabetes and Endocrinology, University of Manchester, Salford Royal Hospitals University Trust, Salford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09513590400027406DOI Listing
March 2005

Apolipoprotein A5 and hypertriglyceridemia.

Clin Chem 2005 Feb;51(2):295-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2004.044826DOI Listing
February 2005

The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.

Am J Cardiovasc Drugs 2004 ;4(4):211-7

University Department of Medicine, Manchester Royal Infirmary, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00129784-200404040-00002DOI Listing
October 2004